<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effects of <z:chebi fb="9" ids="16796">melatonin</z:chebi> (MLT) therapy on <z:hpo ids='HP_0100785'>insomnia</z:hpo> and serum MLT concentration were studied in a 44-year-old man with <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>He suffered from insomia since age 41, and could not sleep well, despite that he was given many kinds of <z:chebi fb="6" ids="35717">hypnotics</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>He showed neither noctural <z:hpo ids='HP_0002871'>central apnea</z:hpo>, inspirative <z:hpo ids='HP_0010307'>stridor</z:hpo>, <z:e sem="disease" ids="C0035258" disease_type="Disease or Syndrome" abbrv="">restless leg syndrome</z:e>, REM without atonia, nor noctural <z:hpo ids='HP_0000103'>polyuria</z:hpo>, <z:hpo ids='HP_0000001'>all</z:hpo> of which are known to cause <z:hpo ids='HP_0100785'>insomnia</z:hpo> in <z:hpo ids='HP_0002503'>spinocerebellar degeneration</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The peak serum level of MLT was low, 9.2 pg/ml </plain></SENT>
<SENT sid="4" pm="."><plain>He was administered 9 mg of MLT p.o. at 8 p.m., and it's peak noctural level elevated to 7,000 pg/ml, and this alleviated his intractable <z:hpo ids='HP_0100785'>insomnia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Our experience indicate that the MLT could be effective for <z:hpo ids='HP_0100785'>insomnia</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> which relates to low MLT concentration </plain></SENT>
</text></document>